Brief: Adalta Says Oribiotech Deal Validates Adalta Manufacturing Strategy
BRIEF-Adalta Says Oribiotech Deal Validates Adalta Manufacturing Strategy Sept 18 (Reuters) - Adalta Ltd 1AD.AX:
ORIBIOTECH DEAL VALIDATES ADALTA MANUFACTURING STRATEGY
ORIBIOTECH SIGNS 10-YEAR PARTNERSHIP WORTH UP TO $120 MILLION FOR IRO PLATFORM
Further company coverage: 1AD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adalta
See all newsAustralia's AdAlta rises on FDA granting orphan drug status to lead cancer therapy
Brief: Adalta Says FDA Assigns Orphan Drug Designation For EW-001 In Mesothelioma To Adalta
Australia's AdAlta surges as partner lands up to $120 million cell therapy deal
Brief: Adalta Says Oribiotech Deal Validates Adalta Manufacturing Strategy
Brief: Adalta Says Regulatory Advisors Appointed For BZDS1901